Today's Most Popular
Amistaff Healthcare Technology, Inc. Announces a New Exam Validation Process to Improve the Quality of Patient Care
Motesanib Shown Active Against Progressive, Differentiated Thyroid Cancer
People Born Preterm at Risk for Medical, Social Disabilities in Adulthood
Jackson Healthcare Solutions Changes Name to Jackson Healthcare
Tech Backs Standards for Online Health Records
2009 Joint Commission Office-Based Surgery Standards Available Online
Big Drug Companies - Continue to Cut Jobs
Lucida Healthcare Group Takes 'Going Mobile' To A New Level
Susan G. Komen for the Cure Employs New Integrated Software
2009 Joint Commission Standards Available Online
Motesanib Shown Active Against Progressive, Differentiated Thyroid Cancer
Article posted from
Americal College of Emergency Physicians (http://www.acep.org/NewsFeed.aspx?id=imn070320081700013842)
Motesanib, an angiogenesis inhibitor, induced partial responses in a phase II study of 93 patients with progressive, locally advanced/metastatic, differentiated thyroid cancer, researchers reported in the July 3 issue of the New England Journal of Medicine.
More Stories in Americal College of Emergency Physicians
- PRoFESS Trial: Stroke Recurrence Comparable with Aspirin Plus Extended-Release Dipyridamole or Clopidogrel Alone
- Gene Variant Protects Against a Form of Age-Related Macular Degeneration
- Magnesium Sulfate to Prevent Cerebral Palsy Yields Mixed Results
- Worldwide Survey Shows People Underestimate Health Behaviors' Link to Cancer
- Progressive Multifocal Leukoencephalopathy Linked to Natalizumab Treatment for Multiple Sclerosis
Other Feedables
NASCAR News - Feeding Your Need For Speed
Belle Feeds - For the feminine palette.
design feeds - artfully satisfying the hunger for knowledge
Good News Feeds - A healtly dose of positive news.
Movie Feeds - Grab the popcorn, shows about to start.- more feedables...
Feedables.com